
Combination of PTH (1-34) with anti-IL17 prevents bone loss by inhibiting IL-17/N-cadherin mediated disruption of PTHR1/LRP-6 interaction
Keywords: PTH; parathyroid hormone; RANKL; receptor activated nuclear factor kappa B ligand; TNF-α; tumor necrosis factor; CTX-1; C-terminal telopeptide; P1NP; pro-collagen type-1 N terminal propeptide; PTH; Osteoporosis; Osteoimmunology; IL-17A;